108 BioCapital has announced that on October 1, 2026, it is leading a new financing round in SedMed, Inc. with a US$4 million investment. SedMed is a medical device company focused on non-electric mobility solutions for older adults and people with limited mobility. The funding is intended to support the company's next stage of commercial growth and expand access to its flagship toilet lift product.
Investment Purpose and Allocation
The new financing will help SedMed accelerate its commercial expansion and grow both its distribution and channel partnerships. The company also plans to advance its intellectual property portfolio and conduct additional hospital-based studies. These initiatives are designed to strengthen SedMed's market position and generate further clinical evidence for healthcare organizations.
Product Design and Practical Impact
SedMed's flagship product is a non-electric toilet lift that attaches to most standard toilets without requiring electricity, batteries, or bathroom remodeling. It provides adjustable sit-to-stand assistance, helping users maintain independence during a daily activity that often poses fall risks. The product is designed for use in private homes, senior living communities, and healthcare environments.
Caregiver and Care Setting Benefits
By reducing the physical effort required to assist someone from the toilet, the device can help lower the risk of caregiver strain and injury. The design also supports use in facilities where electrical work or major renovations may be costly or impractical. SedMed's approach focuses on simple deployment and reliable performance across diverse care settings.
Investor Perspectives
108 BioCapital Managing Partner Sasha Bakhru said SedMed is addressing an important and often overlooked challenge for older adults, individuals with limited mobility, and their caregivers. He described the company's solution as intuitive and capable of improving safety, preserving independence, and reducing caregiver burden. Bakhru added that the firm was impressed by the management team's approach to product development and commercialization.
Validation and International Reach
General Partner Shahryar Oveissi noted that adoption across more than 40 hospital systems demonstrates strong demand for the SedMed solution. He said this momentum positions the company to become a trusted option for older adults living at home, where environmental barriers can increase accident risks. General Partner Shom Jagtiani highlighted meaningful potential beyond the United States, particularly in India and other international markets.
Leadership Outlook
SedMed CEO Jeremy Bronen called the investment an important milestone for the company's mission to make safer bathroom mobility accessible to more people. He said 108 BioCapital brings healthcare expertise and a shared commitment to supporting technologies that improve the lives of patients and caregivers. The new funding will help SedMed expand its commercial reach, strengthen its distribution network, and build additional evidence for healthcare organizations.
Company Profiles
SedMed, Inc. is based in Milford, Connecticut, and develops reliable, non-electric mobility solutions that promote bathroom safety, independence, and dignity. 108 BioCapital is a U.S.-based private equity firm focused on growth-stage investments in biotech and medtech companies. The firm also maintains a feeder vehicle in GIFT City, India, reflecting its interest in international healthcare opportunities.
SedMed's new financing round highlights growing investor interest in practical medical devices that address everyday mobility and safety challenges. The company's non-electric toilet lift has already gained traction across dozens of hospital systems, and the new capital should help extend that reach into home and international settings. With support from 108 BioCapital, SedMed is positioned to strengthen its commercial infrastructure and build further evidence of its product's value.